Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...

A study of almost 13,000 adults with Type 2 diabetes and high systolic blood pressure assessed if a more intensive treatment ...

In the multicenter trial in India, almost 2,000 adults were randomly assigned to one of three treatment groups — to receive a ...

For the last decade, I have been sharing a “mathematical mindset” approach, with free resources for educators and parents ...